Filter Search


Healthcare and Medical


Location Summary Deadline
Germany Completion Of A Non-exclusive Discount Agreement According To Section 130a (8) Sgb V For The Active Ingredient Naproxen + Esomeprazol, Atc M01ae52 F. D. Z. 01.09.2025 - 31.08.2027 (plus Extension Option 1x12 Months) 2026-01-13
United Kingdom Intravenous Cannula And Associated Products 2026-01-13
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Naproxen + Esomeprazole, Atc M01ae52 F. D. Z. 01.09.2025 31.08.2027 (plus Extension Option 1x12 Months) 2026-01-14
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Ruxolitinib, Atc D11ah09 For The Time 01.09.2025 31.08.2027 2026-01-14
Germany Completion Of A Non -excessive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Amifampridine, Atc N07xx05 For The Time 01.09.2025 31.08.2027 (plus Extension Option 1x12 Months) 2026-01-14
Germany Accounts For The Active Substance Lamivudin, Abacavir And Dolutegravir, Atc J05ar13, 67304 Eisenberg Rheinland-pfalz 2026-01-14
Germany Open House Pharmaceutical Contracts For The Active Substance Lamivudin And Dolutegravir, Atc J05ar25, 67304 Eisenberg Rheinland-pfalz 2026-01-14
Germany Open House Pharmaceutical Contracts For The Active Substance Lamivudin And Dolutegravir, Atc J05ar25, 67304 Eisenberg Rheinland-pfalz 2026-01-14
Germany Accounts For The Active Substance Lamivudin, Abacavir And Dolutegravir, Atc J05ar13, 67304 Eisenberg Rheinland-pfalz 2026-01-14
Thailand Announcement Of Bidding For The Purchase Of A Medical Information System For The Internal Medicine Ward 3 And The Cardiovascular Intensive Care Unit, 1 System. 2026-01-14
Whats app